"Indonesia has also sent a reviewer team to closely observe the phase three clinical trial of a candidate vaccine that G42 and Sinopharm are cooperating to develop, and we have in principle agreed for future triangular cooperation between Indonesia, G42, and Sinopharm," Marsudi told journalists in Jakarta on Saturday evening via a virtual press conference from Abu Dhabi. The two officials met with their Emirati counterparts, Foreign Minister Abdullah bin Zayed Al-Nahyan and Suhail bin Mohammed Al Mazrouei, minister of energy and infrastructure, to follow up on various economic cooperations on energy, infrastructure, and agriculture investments worth $22.9 billion, which were secured during President Joko Widodo's visit to the Gulf state in January. This is the second vaccine supply commitment which Indonesia had secured in a week, following a deal with China's biopharmaceutical company Sinovac Biotech, when Marsudi and Thohir visited Sanya on China's Hainan Island earlier this week.